SCHEMBL30780398

SCHEMBL30780398

COc1c(Nc2c(Cl)cnnc2C(N)=O)ncnc1-c1cc(P(=O)(C2CC2)C2CC2)n(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30780331 0.87 TYK2 (0.36) —
SCHEMBL30780310 0.84 SYK (0.37) —
SCHEMBL26983726 0.84 SYK (0.37) —
SCHEMBL30780446 0.79 TYK2 (0.45) —
SCHEMBL26983737 0.79 TYK2 (0.45) —
SCHEMBL30780336 0.79 TYK2 (0.36) —
SCHEMBL30780305 0.76 TYK2 (0.34) —
SCHEMBL30780345 0.75 TYK2 (0.44) —
SCHEMBL24783784 0.74 JAK2 (0.41) —
SCHEMBL30119819 0.73 RET (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551559-A1 HETEROARYL COMPOUNDS AS INHIBITORS OF TYK2/JAK1, COMPOSITION AND APPLICATION THEREOF Accro Bioscience (HK) Limited (HK) 2025-05-14 — — EP disclosed
WO-2024010963-A1 HETEROARYL COMPOUNDS AS INHIBITORS OF TYK2/JAK1, COMPOSITION AND APPLICATION THEREOF ACCRO BIOSCIENCE (HK) LIMITED (CN) 2024-01-11 — — WO disclosed
Send feedback